ANGIOX

This brand name is authorized in Estonia, Lithuania.

Active ingredients

The drug ANGIOX contains one active pharmaceutical ingredient (API):

1	Bivalirudin UNII TN9BEX005G - BIVALIRUDIN
	Bivalirudin is a direct and specific thrombin inhibitor that binds both to the catalytic site and the anion-binding exosite of fluid-phase and clot-bound thrombin.
	Read more about Bivalirudin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Angiox 250mg powder for concentrate for solution for injection or infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AE06	Bivalirudin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1167601
LT	Valstybinė vaistų kontrolės tarnyba	1027375